← brief for 2026-08-21 · Slowing decline

FDA label: 1 INDICATIONS AND USAGE Injectafer is indicated for the trea

Drug label B Peer reviewed Small trial

Key takeaways

This drug replaces iron in patients with kidney disease. A small study of 30 people over 6 weeks showed it was better than oral iron for anemia. Using IV iron can help patients who cannot tolerate oral iron supplements.

Source

Drug label · openFDA, renal drug labels · 2026-08-19
https://open.fda.gov/